Wang et al. compared the role of sST2 with N-terminal probrain natriuretic peptide (NT-proBNP), a classical prognostic biomarker in CKD, on predicting both all-cause and cardiovascular mortality among maintenance hemodialysis (MHD) patients and found the superior role of sST2 [9]. This evidence concerns the gene NPPB and chronic kidney disease.